Zobrazeno 1 - 10
of 74
pro vyhledávání: '"F W M de Rooij"'
Autor:
A. Touw, F W M de Rooij, L. van der Zee, R. Yahya, Adrie J.M. Verhoeven, Eric J.G. Sijbrands, Monique T. Mulder, M. Rashid, Sjaam Jainandunsing
Publikováno v:
Journal of Diabetes and its Complications, 35(10):107993. Elsevier Inc.
Objective: Dyslipidemia precedes type 2 diabetes (T2D) and worsens with increasing glucose intolerance. First degree relatives of T2D patients have an increased risk to develop dyslipidemia and glucose intolerance. The aim of the present study was to
Autor:
Michael Buchfelder, Sanne E Franck, A. J. van der Lely, Richard A Feelders, Leo J. Hofland, Jens Otto Lunde Jørgensen, Alof H G Dallenga, F. W. M. de Rooij, S.J.C.M.M. Neggers, Joseph A M J L Janssen, R. M. L. Poublon
Publikováno v:
Neggers, S J C M M, Franck, S E, de Rooij, F W M, Dallenga, A H G, Poublon, R M L, Feelders, R A, Janssen, J A M J L, Buchfelder, M, Hofland, L J, Jørgensen, J O L & van der Lely, A J 2014, ' Long-term efficacy and safety of pegvisomant in combination with long-acting somatostatin analogs in acromegaly ', Journal of Clinical Endocrinology and Metabolism, vol. 99, no. 10, pp. 3644-52 . https://doi.org/10.1210/jc.2014-2032
Journal of Clinical Endocrinology and Metabolism, 99(10), 3644-3652. Endocrine Society
Journal of Clinical Endocrinology and Metabolism, 99(10), 3644-3652. Endocrine Society
BACKGROUND: Treatment for acromegaly patients with long-acting somatotropin release-inhibiting factor (LA-SRIF) often does not result in complete normalization of IGF-1. Addition of pegvisomant (PEGV), a GH receptor antagonist, could improve this; ho
Autor:
Colin R. Goding, Hetanshi Naik, Henry W. Lim, Iltefat H. Hamzavi, Gillian M. Murphy, Karl E. Anderson, Alexander Vincent Anstey, Christopher J Edwards, Mark Lebwohl, Raili Kauppinen, Janneke G. Langendonk, Eric J.G. Sijbrands, Herbert L. Bonkovsky, Joseph R. Bloomer, Jorge Frank, Charles J. Parker, Manisha Balwani, John D. Phillips, Robert J. Desnick, Lesley E. Rhodes, Jean-Charles Deybach, F W M de Rooij, F. P J Karstens, Norbert J. Neumann, J.H.P. Wilson, D M Bissell
Publikováno v:
New England Journal of Medicine, 373(1), 48-59. Massachussetts Medical Society
BACKGROUND Erythropoietic protoporphyria is a severe photodermatosis that is associated with acute phototoxicity. Patients with this condition have excruciating pain and a markedly reduced quality of life. We evaluated the safety and efficacy of an a
Autor:
X. Gao, Q Gu, M. van Hoek, Mojgan Yazdanpanah, A. Hofman, F W M de Rooij, Eric J.G. Sijbrands
Publikováno v:
Journal of Human Hypertension, 29(2), 82-86. Nature Publishing Group
Proprotein convertase subtilisin/kexin-type 1 (PCSK1) activates precursors pro-opiomelanocortin (POMC), proinsulin and prorenin. We investigated if common variants in the PCSK1 gene influence blood pressure and risk of hypertension. Additionally, we
Autor:
A. Edixhoven, E. M. Terlouw, F W M de Rooij, H. van Dekken, J.H.P. Wilson, P. Hinnen, Peter D. Siersema, H. W. Tilanus, R. Van Hillegersberg
Publikováno v:
British Journal of Cancer
British Journal of Cancer, 83(4), 539-543. Nature Publishing Group
British Journal of Cancer, 83(4), 539-543. Nature Publishing Group
5-Aminolaevulinic acid (ALA)-induced porphyrin biosynthesis, which is used for ALA-based photodynamic therapy (ALA-PDT), was studied in tissues of 10 patients with Barrett’s oesophagus (BE) and adenocarcinoma of the oesophagus (AC) undergoing oesop
Publikováno v:
British Journal of Surgery, 87, 231-235. John Wiley & Sons Ltd.
Background Photosensitized patients are exposed to bright lights when undergoing intraoperative photodynamic therapy or fluorescence measurements. Acrylate yellow filters might reduce unwanted tissue damage. Methods To investigate the protective valu
Autor:
K. Te Velde, Hervé Puy, Jérôme Lamoril, V. Da Silva, Laurent Gouya, F. W. M. De Rooij, Jean Charles Deybach, Pavel Martásek, R. Rosipal, Yves Nordmann
Publikováno v:
Human Mutation, 13, 44-53. Wiley-Liss Inc.
Hereditary coproporphyria (HC) is an acute hepatic porphyria with autosomal dominant inheritance caused by deficient activity of coproporphyrinogen III oxidase (CPO). Clinical manifestations of the disease are characterized by acute attacks of neurol
Publikováno v:
Journal of inherited metabolic disease. 33
The main symptom of patients with erythropoietic protoporphyria (EPP) is painful photosensitivity, starting within minutes of sun exposure and leading to sun-avoidance. As 80-100% of vitamin D is synthesized under the influence of sunlight, we invest
Publikováno v:
Scandinavian Journal of Gastroenterology. 27:66-70
Primary bile acid malabsorption is defined as chronic diarrhoea with bile acid malabsorption of unknown cause and a symptomatic response to cholestyramine. Convincing evidence of the proposed pathophysiology--a defect of the active bile acid absorpti
Publikováno v:
Cellular and molecular biology (Noisy-le-Grand, France). 55(2)
Acute intermittent porphyria (AIP), the most common acute hepatic porphyria, is an autosomal dominant inborn disorder of heme biosynthesis caused by mutations in the porphobilinogen deaminase (PBGd) gene. The prevalence of AIP in Europe is estimated